Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Financing Activities: 2017-2024

Historic Cash from Financing Activities for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $214.5 million.

  • Cogent Biosciences' Cash from Financing Activities fell 68.88% to $38.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $160.1 million, marking a year-over-year decrease of 31.04%. This contributed to the annual value of $214.5 million for FY2024, which is 31.13% up from last year.
  • As of FY2024, Cogent Biosciences' Cash from Financing Activities stood at $214.5 million, which was up 31.13% from $163.5 million recorded in FY2023.
  • Over the past 5 years, Cogent Biosciences' Cash from Financing Activities peaked at $232.2 million during FY2020, and registered a low of $38.0 million during FY2021.
  • Moreover, its 3-year median value for Cash from Financing Activities was $163.6 million (2022), whereas its average is $180.5 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 214,896.30% in 2020, then crashed by 83.64% in 2021.
  • Over the past 5 years, Cogent Biosciences' Cash from Financing Activities (Yearly) stood at $232.2 million in 2020, then tumbled by 83.64% to $38.0 million in 2021, then soared by 330.69% to $163.6 million in 2022, then declined by 0.01% to $163.5 million in 2023, then skyrocketed by 31.13% to $214.5 million in 2024.